SHIELDS MATTHEW (EVP, Global Operations) sold 63.4% of their position (17.30K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $547.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/9/2026ACC: 0001193125-26-098473
Officer· EVP, Global Operations
Since Mar 2026
-17.30K
Net shares
Net seller
$547.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
17.30K acquired · 34.59K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+17.30K
Price / share
—
Trade value
—
% of position
173.1%
3/5/2026
9.99K→27.28K
Ordinary Shares
Direct
Shares
−17.30K
Price / share
$31.67
Trade value
$547.70K
% of position
63.4%
3/5/2026
27.28K→9.99K
Total
Net shares
+0.00
Net value
-$547.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/5/2026 | M · Option Exercise | +17.30K | — | — | 173.1% | 9.99K | 27.28K |
| Ordinary Shares Direct | 3/5/2026 | S · Sale | −17.30K | $31.67 | $547.70K | 63.4% | 27.28K | 9.99K |
| Total | +0.00 | -$547.70K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
17.30K shares
Shares
−17.30K
Strike price
Held after
51.89K
Exercisable
—
3/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares17.30K shares | 3/5/2026 | M · Option Exercise | −17.30K | — | 51.89K |